Real-time RT-PCR analysis of 54 glioma samples showed that TET1 and TET2 mRNA was expressed at varying levels in primary glioblastomas, secondary glioblastomas, and anaplastic astrocytomas. The gene discussed is TET1; the disease is central nervous system cancer.